Kolon TissueGene, Inc. — Form D

Kolon TissueGene, Inc. of ROCKVILLE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-15. The offering totals $30.0M, of which $30.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Sung Su HanDirectorRockville, MD
Jung In Su KimDirectorRockville, MD
Sun Joo Su LeeDirectorRockville, MD
Moon Jong Su NohDirectorRockville, MD
Diana Stephen HalimExecutive OfficerRockville, MD
Sung Su HanExecutive OfficerRockville, MD
Jung In Su KimExecutive OfficerRockville, MD
Moon Jong Su NohExecutive OfficerRockville, MD
Charles Stephen NyeExecutive OfficerRockville, MD
Gun Young Stephen ParkExecutive OfficerRockville, MD
Soon-Wook Joon KweonExecutive OfficerRockville, MD
Yonggyun Joon JeongExecutive OfficerRockville, MD
Gun Young Joon ParkExecutive OfficerRockville, MD
Sun Jin Joon KimExecutive OfficerRockville, MD
Jung In KimDirectorRockville, MD
Jung In KimExecutive OfficerRockville, MD
Sun Joo LeeDirectorRockville, MD
Charles Joon NyeExecutive OfficerRockville, MD
Young Joon KimExecutive OfficerRockville, MD
Diana HalimExecutive OfficerRockville, MD
Moon Jong NohDirectorRockville, MD
Moon Jong NohExecutive OfficerRockville, MD
Jangik Su LeeDirectorRockville, MD
Min Seok Su KimDirectorRockville, MD
Min Seok Su KimExecutive OfficerRockville, MD

Other filings by this issuer (3)

FiledFormOfferingSold
2024-06-05D$35.0M$35.0M
2022-08-29D$29.6M$29.6M
2021-12-16D$30.1M$30.1M

More